secwatch.observer — SEC 8-K summary
======================================

Issuer:     OmniAb, Inc. (OABI)
CIK:        0001846253
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001846253-23-000117
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OmniAb Q3 revenue falls 20% to $5.5M; net loss widens to $15.7M
---------------------------------------------------------------

- Q3 2023 revenue $5.5M (down 20% YoY); net loss $15.7M ($0.16/share) vs $12.6M loss in Q3 2022.
- Active partner programs 314, up from 291 at year-start; added Novartis, GigaMune, Polaris as new partners.
- Cash & short-term investments $96.6M at Sep 30; expects year-end cash slightly below year-end 2022.
- Nine-month revenue $29.3M (up 24% YoY) from milestone payments; net loss $36.6M ($0.37/share).
- Appointed Steve Love to Board (Audit Chair) and Yasmina Abdiche as VP of Exploratory Research.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1846253/000184625323000117/0001846253-23-000117-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1846253/000184625323000117/oabi-20231109.htm
  HTML page:      https://secwatch.observer/filing/0001846253-23-000117

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer